05/06/2024
4:30 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:43 PM | INVO Bioscience (Filer)
| Form 10-K/A | |
04/19/2024
4:18 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
4:02 PM | INVO Bioscience (Filer)
| Form 10-K/A | |
04/17/2024
2:15 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:50 PM | INVO Bioscience (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/16/2024
3:56 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/11/2024
4:28 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
4:19 PM | INVO Bioscience (Filer)
| Form 8-K/A | |
04/01/2024
3:18 PM | INVO Bioscience (Filer)
| Form NT 10-K | |
03/29/2024
3:41 PM | INVO Bioscience (Filer)
| Form 424B5 | |
03/27/2024
4:24 PM | INVO Bioscience (Filer)
| Form 10-K/A | |
03/01/2024
4:16 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2024
9:24 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
INVO Bioscience (Subject)
| Form SC 13G/A | |
02/01/2024
8:01 AM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
4:29 PM | INVO Bioscience (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
01/10/2024
3:46 PM | INVO Bioscience (Filer)
| Form 8-K/A | |
01/03/2024
4:29 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
4:02 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
4:04 PM | INVO Bioscience (Filer)
| Form 424B7 | |
12/27/2023
4:45 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
4:08 PM | INVO Bioscience (Filer)
| Form DEFA14A | |
12/13/2023
3:53 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
4:18 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
12:08 PM | INVO Bioscience (Filer)
| Form DEF 14A | |
11/13/2023
8:21 AM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
8:23 AM | INVO Bioscience (Subject)
| Form SC TO-C | |
11/13/2023
8:12 AM | INVO Bioscience (Filer)
| Form PRE 14A | |
10/24/2023
4:10 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
5:15 AM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
3:28 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
4:24 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
4:12 PM | INVO Bioscience (Filer)
| Form DEFA14A | |
09/29/2023
4:26 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
11:45 AM | INVO Bioscience (Filer)
| Form DEFA14A | |
09/08/2023
3:34 PM | AWM Investment Company, Inc. (Filed by)
INVO Bioscience (Subject)
| Form SC 13G/A | |
09/01/2023
4:17 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
8:55 AM | INVO Bioscience (Filer)
| Form DEF 14A | |
08/21/2023
3:33 PM | INVO Bioscience (Filer)
| Form PRE 14A | |
08/11/2023
1:07 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
11:15 PM | INVO Bioscience (Filer)
| Form EFFECT | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
08/02/2023
11:58 AM | INVO Bioscience (Filer)
| Form S-1/A | |
07/31/2023
5:06 AM | INVO Bioscience (Filer)
| Form S-1/A | |
07/31/2023
5:15 AM | INVO Bioscience (Subject)
| Form FWP | |
07/27/2023
4:16 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
5:13 AM | INVO Bioscience (Filer)
| Form S-1/A | |
07/21/2023
4:50 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
4:29 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
3:05 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
1:37 PM | INVO Bioscience (Filer)
| Form 424B3 | |
07/09/2023
11:15 PM | INVO Bioscience (Filer)
| Form EFFECT | |
07/07/2023
3:17 PM | INVO Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
12:43 PM | INVO Bioscience (Filer)
| Form S-1/A | |
06/30/2023
4:23 PM | INVO Bioscience (Filer)
| Form 8-K/A | |
06/23/2023
3:06 PM | INVO Bioscience (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/21/2023
11:55 AM | INVO Bioscience (Filer)
| Form 8-K/A | |
05/22/2023
6:56 PM | Campbell Michael Jos. (Reporting)
INVO Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
6:58 PM | DAVIS TRENT D (Reporting)
INVO Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
7:01 PM | Goren Andrea (Reporting)
INVO Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
7:04 PM | INVO Bioscience (Issuer)
Messina Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
7:07 PM | INVO Bioscience (Issuer)
Ryan Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
7:09 PM | INVO Bioscience (Issuer)
Shum Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
7:13 PM | INVO Bioscience (Issuer)
Szot Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
